Matthew Jeffrey Ferris MD
Head & Neck, Skin Cancer, Thoracic Cancer
Head/Neck/Thoracic/Skin Radiation Oncology │ Medical Director, Maryland Proton Treatment Center │ Department of Radiation Oncology, University of Maryland School of Medicine
Maryland Proton Treatment Center850 W. Baltimore St.Baltimore, MD 21201
Fax+1 410-347-0870
Overview of Dr. Ferris
Dr. Matthew Ferris is a radiation oncologist in Baltimore, MD and is affiliated with University of Maryland Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 2 years. He is one of 53 doctors at University of Maryland Medical Center who specialize in Radiation Oncology. He has more than 40 publications and over 350 citings.
Education & Training
Emory University School of MedicineResidency, Radiation Oncology, 2014 - 2019
University of Maryland School of MedicineClass of 2014
Loyola University MarylandBS, Biology, Summa Cum Laude; Business Minor; English Minor, 2006 - 2010
Certifications & Licensure
MD State Medical License 2019 - 2026
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Inductee Phi Beta Kappa Society, 2009
- Inductee Alpha Omega Alpha Honor Medical Society
Publications & Presentations
PubMed
- Graph feature selection for enhancing radiomic stability and reproducibility across multiple institutions in head and neck cancer.Hajar Moradmand, Jason Molitoris, Xiao Ling, Lisa Schumaker, Erin Allor
Scientific Reports. 2025-07-31 - Optimizing quality assurance CT schedules during adaptive proton therapy for enhanced patient care.Nrusingh C Biswal, Mark J Zakhary, Abdul K Parchur, Ruslan Mogilnay, Matthew J Ferris
Journal of Applied Clinical Medical Physics. 2025-07-01 - Bulky non-small cell lung cancer treated with two-field robust proton lattice boost followed by conventional chemoradiation.Matthew J Ferris, Sina Mossahebi, Jenna Jatczak, Jason K Molitoris, Zaker H Rana
Clinical and Translational Radiation Oncology. 2025-07-01
Journal Articles
- Targeted Sequencing and Intracranial Outcomes of Patients with Lung Adenocarcinoma Brain Metastases Treated with RadiotherapyGabriel L Sica, Matthew J Ferris, Walter J Curran, Shannon Kahn, Suresh S Ramalingam, Pretesh R Patel, Rathi N Pillai, Robert H Press, Jim Zhong, Conor E Steuer, Taofe..., Cancer
Authored Content
- Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
- Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
- Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
Press Mentions
Cancer treatment advances are helping patients and dropping death ratesFebruary 17th, 2020
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
